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Preparation of substituted tetrahydro-1-benzazepines by 
lithiationÐtrapping 
Tahani Aeyad,[a] Callum G. Jones,[a] and Iain Coldham*[a] 
Abstract: The tetrahydro-1-benzazepine or benzo[b]azepine ring 
system is found in a number of drug molecules although methods to 
access 2,2-disubstituted derivatives are rare. Here we report the 
preparation of N-tert-butoxycarbonyl-2-phenyltetrahydro-1-
benzazepine followed by lithiation and trapping with electrophiles. 
The metallation reaction was optimized by using React-IR 
spectroscopy, and VT-NMR spectroscopy allowed the determination 
of the rate of rotation of the Boc group (approximate ΔGà 63 kJ/mol 
at Ð50 ¡C). The resulting organolithium was quenched to give either 
2,2-disubstituted products or, with certain electrophiles, the ortho-
substituted products, presumably through an η3-coordinated 
benzyllithium intermediate. The chemistry was shown to be 
amenable to extension to the 7-methoxy analog. Removal of the Boc 
group from the nitrogen atom led to amine products. 
Introduction 
The tetrahydro-1-benzazepine ring system is found in a number 
of compounds with biological activity and has potential as a 
building block for drug discovery.1 Some examples of 1-
benzazepines include the vasopressin receptor antagonist 
tolvaptan (1) and the anti-diuretic fedovapagon (2) (Fig. 1).2 
Many routes have been developed for the synthesis of 
tetrahydro-1-benzazepines,3 although the formation of 2,2-
disubstituted derivatives is relatively rare.4 Our research group 
has reported chemistry to prepare 2,2-disubstituted 
tetrahydroquinolines,5 azepanes,6 and other alpha-amino 
substituted compounds7 by using a lithiationÐtrapping protocol. 
We were therefore interested to extend this chemistry to 1-
benzazepines. Although lithiation next to a nitrogen atom 
followed by electrophilic quench is well-known for pyrrolidines 
and piperidines,8 there is only one example, as far as we are 
aware, of this type of reaction with a tetrahydro-1-benzazepine, 
in which Meyers and Milot prepared a small selection of mono-
substituted products.9 The most popular directing group on the 
nitrogen atom is the N-tert-butoxycarbonyl (N-Boc) group which 
promotes lithiation alpha to the nitrogen atom and we therefore 
needed access to N-Boc-2-aryltetrahydro-1-benzazepines. 
 
Figure 1. Biologically active 1-benzazepines. 
Results and Discussion 
The tetrahydro-1-benzazepine compound 6 was prepared by the 
addition of phenylmagnesium bromide to the benzotriazole 5 
(Scheme 1). The benzotriazole 5 was made from the 
commercially available lactam 3 by Boc protection to give lactam 
4, partial reduction with iBu2AlH (DIBAL-H) and reaction with 
benzotriazole, following literature precedent on a related 
lactam.6,10 The partial reduction of lactam 4 provided a mixture of 
the alcohol and the ring-opened aldehyde product, but this 
mixture was amenable to conversion directly to the 
benzotriazole compound 5 in good overall yield (75%). The 
Grignard addition step was performed in Et2O with some THF to 
aid solubility. Reaction in neat THF resulted in a lower yield of 
the product 6 and the reaction was best conducted in a mixture 
of Et2OÐTHF. The structure of the tetrahydro-1-benzazepine 6 
was verified by single crystal X-ray analysis (see SI). This 
showed a torsion angle between the fused aromatic ring and the 
NÐCO bond of 67¡, suggesting poor overlap between the 
nitrogen p-orbital and this aromatic ring. 
 
Scheme 1. Preparation of the carbamate 6 (Bt = benzotriazolyl). 
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The lithiation of the 1-benzazepine 6 was successful by using 
nBuLi in THF. The optimum temperature and time was verified 
by in situ ReactIR spectroscopy (Fig. 2). The lithiation was slow 
at Ð78 ¡C but at Ð50 ¡C the reaction was complete in a few 
minutes, as judged by the formation of a new carbonyl stretch,  
νC=O at 1644 cm
Ð1 for the lithiated compound. 
 
Figure 2. ReactIR spectra for lithiation of 6 with nBuLi added after about 12 
min in THF at Ð50 ¡C; νC=O at 1702 cm
Ð1 for 6 and νC=O at 1644 cm
Ð1 for 
lithiated 6 (Time in h:min:sec). 
 
The slow lithation at Ð78 ¡C is due to the slow rotation around 
the NÐCO bond combined with the requirement for the carbonyl 
group to be directed towards the benzylic proton for lithiation to 
occur.11 1H NMR spectroscopy indicated that the two rotamers 
were present in about 1.2:1 ratio and variable temperature NMR 
spectroscopy was performed (Fig. 3). By using line shape 
analysis, the activation parameters can be estimated and this 
led to approximate values of ΔHà 56 kJ/mol and ΔSà Ð32 J/Kámol. 
These results, albeit in DMSO as the solvent (to allow for 
elevated temperatures to observe coalescence), give a half-life 
for rotation of about 2 h at Ð78 ¡C but only about 80 s at Ð50 ¡C. 
These data match those found using in situ ReactIR 
spectroscopy and verify that the best conditions for lithiation use 
the higher temperature. 
 
Figure 3. 1H NMR spectra of 1-benzazepine 6 in D6-DMSO showing region 
5.30Ð2.60 ppm. 
The barrier to rotation of the Boc group is about 63 kJ/mol at Ð
50 ¡C and this is lower than that for the related azepane 
(approximate ΔGà 71 kJ/mol at Ð50 ¡C).5 The faster rate of 
rotation is likely due to at least partial conjugation of the nitrogen 
lone pair with the aromatic ring, thereby reducing the interaction 
with the carbonyl group. However this conjugation will be 
tempered by the lack of planarity and the value of 63 kJ/mol is 
significantly higher than that for the corresponding 
tetrahydroquinoline (approximate ΔGà 47 kJ/mol at Ð50 ¡C) 
where the torsion angle is lower.5 
 
Using the data above, we treated the 1-benzazepine 6 with 
nBuLi (1.2 equivalents) in THF at Ð50 ¡C. After 10 min, the 
organolithium intermediate was trapped with a range of different 
electrophiles to give the products 7aÐf (Scheme 2). The 
products 7aÐf were formed with good yields in which the 
electrophile adds at C-2 of the benzazepine ring. The reaction 
was successful for tributyltin chloride, alkyl and allyl halides, and 
for carbonyl electrophiles. In the latter case the intermediate 
alkoxide cyclizes on to the Boc group to give the cyclic 
carbamate. With benzaldehyde as the electrophile, the trapping 
occurred stereoselectively to give the product 7f as the major 
(separable) isomer with the phenyl groups trans to each other. 
This was verified by single crystal X-ray analysis (Fig. 4). 
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Scheme 2. LithiationÐtrapping to give the carbamates 7aÐf. 
 
Figure 4. Crystal structure of the major isomer of the carbamate 7f. 
In previous work with N-Boc-2-phenylazepane and N-Boc-2-
phenyltetrahydroquinoline, we had found that lithiation followed 
by addition of alkyl cyanoformate electrophiles provided the 
unusual ortho-substituted products.5,6 We therefore tested this 
with methyl cyanoformate and found the same type of switch to 
the ortho-substituted product 8a (Scheme 3). The same product 
8a was also formed by using methyl chloroformate as the 
electrophile. In addition, the ortho-substituted product 8b was 
formed on using the electrophile PhSSO2Ph. These data, 
combined with those from the ReactIR and Scheme 2, suggest 
that the lithium atom in the intermediate organolithium species 
(typically drawn as if located at C-2 of the benzazepine with 
coordination to the Boc carbonyl group) has η3-coordination to 
the phenyl group. Both η1- and η3-coordination of benzyllithiums 
is known.12 Density functional theory calculations with the 
related tetrahydroquinoline system suggest that coordination of 
a cyanoformate to the lithium atom alters the structure of the 
organolithium towards the η3-coordination mode.5 This is 
presumably also the case here with the 1-benzazepine not only 
with cyanoformates but also with certain other electrophiles 
(MeOCOCl and PhSSO2Ph). After reaction at the ortho position, 
rearomatization would provide the products 8aÐb. In contrast, 
alkyl halides and aldehydes/ketones react at C-2 (Scheme 2) 
suggesting that the organolithium is located predominantly on C-
2 and that these electrophiles interact differently (in comparison 
with, for example, formates) during reaction with the 
organolithium species. 
 
Scheme 3. LithiationÐtrapping to give the carbamates 8aÐb. 
To illustrate the relevance of the chemistry, we treated the 
carbamates 7d and 8a with trifluoroacetic acid (TFA) at room 
temperature in CH2Cl2 to give new products 9 and 10 (Scheme 
4). The secondary amine 10 was formed from carbamate 8a 
although the amine product generated by removal of the Boc 
group from carbamate 7d cyclized in situ with displacement of 
bromide to give the tricyclic amine product 9 in high yield. Fused 
tricyclic amines with an aryl group alpha to the nitrogen atom are 
of interest in synthetic and medicinal chemistry and are present 
in biologically active compounds such as antidepressants and N-
methyl-D-aspartate receptor antagonists.13  
 
Scheme 4. Removal of the Boc group to give amines 9Ð10. 
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Finally, we have demonstrated that the chemistry is amenable to 
a derivative, namely the 7-methoxy analog 13. The carbamate 
13 was prepared from the commercially available ketone 11 
following related literature methods (Scheme 5).14,15 Reduction 
of the oxime to give the hydroxylamine 12 is reported with 
sodium cyanoborohydride in acetic acid.14 We found that the 
presence of acetic acid led to difficulties in isolation of 
hydroxylamine 12, and it was preferable to use hydrochloric acid 
instead. The hydroxylamine 12 was treated with phenyllithium to 
promote loss of methoxide, rearrangement and addition of the 
phenyl group.15 The lithiated secondary amine could be 
protonated according to the literature but the subsequent 
conversion to the carbamate 13 with a base and Boc2O was 
unsatisfactory in terms of yield. However, rather than isolate the 
secondary amine, direct addition of Boc2O to the lithiated 
intermediate resulted in a good yield for in situ one-pot formation 
of the carbamate 13. 
In the same way as the 1-benzazepine 6, treatment of the 1-
benzazepine 13 with nBuLi in THF at Ð50 ¡C for 10 min was 
followed by addition of a selection of electrophiles (Scheme 6). 
We were pleased to find that this gave good yields of the 
substituted products 14Ð16. The reactivity matched that of the 1-
benzazepine 6, where addition of acetone gave the cyclic 
carbamate (15) and addition of ethyl chloroformate resulted in 
the ortho-substituted product (16). 
 
Scheme 5. Preparation of the carbamate 13. 
 
Scheme 6. LithiationÐtrapping of the carbamate 13. 
Conclusions 
A selection of substituted 2-aryltetrahydro-1-benzazepines can 
be prepared by lithiation then trapping with different electrophiles. 
Variable temperature NMR spectroscopy, which provides 
knowledge of the rate of rotation of the Boc group, and in situ 
ReactIR spectroscopy were found to be suitable methods by 
which the lithiation reactions can be optimised. Alkyl halides, 
tributyltin chloride, aldehydes and ketones lead to the 2,2-
disubstituted products. However, chloroformates, cyanoformates, 
and PhSSO2Ph lead to ortho substituted products. This may be 
due to a change in the structure (η1 or η3) of the organolithium 
as it reacts with/coordinates to the different electrophiles.4 The 
products can be converted to amines by removal of the Boc 
group. 
Experimental Section 
General details: Reagents were obtained from commercial suppliers and 
were used without further purification except for methyl chloroformate, 
allyl bromide, benzaldehyde, and 1,4-dibromobutane that were used after 
distillation; nBuLi was titrated before use. Solvents were obtained from a 
Grubbs dry solvent system. Thin layer chromatography was performed 
on Merck silica gel 60F254 plates and visualised by UV irradiation at 254 
nm or by staining with an alkaline KMnO4 dip. Flash column 
chromatography was performed using DAVISIL or Geduran silica gel (40-
63 micron mesh). Melting points were recorded on a Gallenkamp hot 
stage and were uncorrected. InfraRed spectra were recorded on a Perkin 
Elmer Spectrum RX Fourier Transform Ð IR System and only selected 
peaks are reported. 1H NMR spectra were recorded on a Bruker AC400 
(400 MHz) instrument. Chemical shifts are reported in ppm with respect 
to the residual solvent peaks, with multiplicities given as s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, br = broad. Coupling 
constants (J values) are quoted to the nearest 0.5 Hz with values in Hertz 
(Hz). 13C NMR spectra were recorded on the above instrument at 100 
MHz. Low and high resolution (accurate mass) mass spectra were 
recorded on a Walters LCT instrument for ElectroÐSpray (ES). ReactIR 
infrared spectroscopic monitoring was performed on a Mettler-Toledo 
ReactIR iC 4000 spectrometer equipped with a diamond-tipped (DiComp) 
probe. 
tert-Butyl 2,3,4,5-Tetrahydro-2-oxobenzo[b]azepine-1-carboxylate 4: 
Di-tert-butyl dicarbonate (4.7 g, 20 mmol) in dry THF (15 mL) was added 
to commercially available 2,3,4,5-tetrahydro-1H-1-benzazepin-2-one 3 
(3.0 g, 19 mmol) and 4-(N,N-dimethylamino)pyridine (2.5 g, 20 mmol) in 
dry THF (50 mL) at room temperature. After 3 h, the solvent was 
evaporated and EtOAc (50 mL) was added. The mixture was washed 
with aqueous HCl (3 × 50 mL, 0.5 M), saturated brine solution (3 × 25 mL) 
and saturated NaHCO3 solution (3 × 25 mL). The organic layer was dried 
(MgSO4) and the solvent was evaporated. Purification by flash silica 
chromatography, eluting with CH2Cl2ÐMeOH (95:5), gave the carbamate 
4 (4.5 g, 93%) as an amorphous solid; m.p. 110Ð112 ¼C; Rf  0.26 [petrolÐ
EtOAc (70:30)]; FT-IR νmax (film)/cm
Ð1 2980, 2930, 2860, 1765, 1715; 1H 
NMR (400 MHz, CDCl3) δ = 7.39Ð7.20 (3H, m, 3 × CH), 7.19Ð7.05 (1H, 
m, CH), 2.81 (2H, t, J = 7.0 Hz, CH2), 2.28 (2H, t, J = 7.0 Hz, CH2), 2.19Ð
2.05 (2H, m, CH2), 1.47 (9H, s, t-Bu); 
13C NMR (100 MHz, CDCl3) δ = 
172.6, 151.4, 138.8, 135.5, 129.0, 127.8, 127.1, 126.1, 83.5, 34.7, 29.3, 
27.8, 27.5; HRMS (ES) Found: MH+, 262.1443. C15H20NO3 requires MH
+, 
262.1438; LRMS m/z (ES) 262 (5%, MH+), 206 (100). 
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tert-Butyl-2-(1H-Benzo[d][1,2,3]triazol-1-yl)-2,3,4,5-
tetrahydrobenzo[b]azepine-1-carboxylate 5: DIBAL-H (21.4 mL, 21.4 
mmol, 1 M in cyclohexane) was added dropwise to the carbamate 4 (4.0 
g, 15 mmol) in dry THF (50 mL) at Ð78 ¼C. After 1 h, the mixture was 
allowed to warm to room temperature over a further 1 h. Saturated 
aqueous potassium acetate solution (20 mL) was added slowly. The 
solids were removed by filtration and were washed with EtOAc (3 × 25 
mL). The organic layers were combined, washed with saturated brine 
solution (4 × 25 mL), dried (MgSO4), and the solvent was evaporated. 
Purification by flash silica chromatography, eluting with CH2Cl2ÐMeOH 
(95:5), gave a mixture of the 2-hydroxy compound and the aldehyde (3.6 
g, 89%) (ratio 60:40) as an oil; Rf 0.50 (alcohol), 0.75 (aldehyde) 
[CH2Cl2ÐEtOAc (90:10)]; FT-IR νmax (film)/cm
Ð1 3450, 3360, 2970, 2980, 
2940, 2870, 1710, 1680; 1H NMR (400 MHz, CDCl3, mixture of isomers) 
δ = 9.82 (0.4H, t, J = 1.0 Hz, CHO), 7.82 (0.4H, d, J = 8.0 Hz, CH), 7.25Ð
7.19 (1.6H, m, CH), 7.17Ð7.11 (1.6H, m, CH), 7.04Ð7.01 (0.4H, m, CH), 
6.80 (0.4H, br s, NH), 5.71Ð5.54 (0.6H, m, CH), 3.92 (0.6H, s, OH), 2.75 
(0.6H, td, J = 13.0, 7.0 Hz, CH), 2.62Ð2.54 (2.4H, m, 4 × CH), 1.95Ð1.77 
(2.2H, m, CH), 1.55 (3.7H, s, t-Bu), 1.54Ð1.52 (0.8H, m, CH), 1.40 (5.3H, 
s, t-Bu); 13C NMR (100 MHz, CDCl3, mixture of isomers) δ = 202.4, 155.5, 
153.6, 137.1, 136.5, 136.1, 131.0, 129.4, 129.2, 128.9, 128.3, 127.1, 
126.5, 123.9, 122.2, 80.8, 80.3, 78.9, 43.0, 30.6, 29.7, 29.4, 28.4, 28.3, 
22.0, 21.2; HRMS (ES) Found: MNa+, 286.1417. C15H21NO3Na requires 
MNa+, 286.1414; LRMS m/z (ES) 286 (5%, MH+), 190 (100), 146 (85). It 
was possible to separate the aldehyde from this mixture and its data are 
as follows: 1H NMR (400 MHz, CDCl3) δ = 9.83 (1H, br s, CHO), 7.84 (1H, 
d, J = 8.0 Hz, CH), 7.25Ð7.20 (1H, m, CH), 7.13 (1H, d, J = 7.0 Hz, CH), 
7.07Ð7.01 (1H, m, CH), 6.80 (1H, br s, NH), 2.63Ð2.54 (4H, m, 4 × CH), 
1.95Ð1.84 (2H, m, 2 × CH), 1.55 (9H, s, t-Bu); 13C NMR (100 MHz, CDCl3) 
δ = 202.3, 153.5, 136.0, 131.0, 129.4, 127.1, 123.9, 122.0, 80.3, 43.0, 
30.6, 28.4, 22.0. Benzotriazole (2.0 g, 17 mmol) and MgSO4 (0.5 g) were 
added to this mixture (3.0 g, 11 mmol) in toluene (70 mL). The mixture 
was heated under reflux for 18 h then was allowed to cool to room 
temperature, before washing with saturated aqueous NaCO3 solution (3 
× 20 mL) and saturated brine solution (3 × 20 mL). The organic layers 
were dried (MgSO4) and the solvent was evaporated. Purification by flash 
silica chromatography, eluting with petrolÐEtOAc (75:25), gave the 
carbamate 5 (3.50 g, 84%), as an oil; Rf 0.45 [petrolÐEtOAc (70:30)]; FT-
IR νmax (film)/cm
Ð1 3025, 2970, 1690; 1H NMR (400 MHz, CDCl3) δ = 
8.08Ð7.43 (3H, m, 3 × CH), 7.42Ð7.02 (5H, m, 3 × CH), 6.90Ð6.62 (1H, m, 
NCH), 3.06Ð2.93 (1H, m, CH), 2.83Ð2.68 (1H, m, CH), 2.54Ð1.84 (4H, m, 
4 × CH), 1.33 (9H, s, t-Bu); 13C NMR (100 MHz, CDCl3, the C=O could 
not be observed) δ = 143.9, 137.6, 136.8, 136.5, 128.7, 128.2, 127.3, 
126.1, 123.9, 119.7, 118.5, 110.6, 79.0, 66.8, 29.9, 29.6, 29.1, 28.1; 
HRMS (ES) Found: MNa+, 387.1793. C21H24N4O2Na, requires MNa
+, 
387.1791; LRMS m/z (ES) 387 (15% MNa+), 190 (28), 146 (100). 
tert-Butyl 2,3,4,5-Tetrahydro-2-phenylbenzo[b]azepine-1-carboxylate 
6: Phenylmagnesium bromide solution (14.6 mL, 44 mmol, 3 M in Et2O) 
was added dropwise to the carbamate 5 (4.0 g, 11 mmol) in dry Et2OÐ
THF (100 mL, 9:1) at 0 ¡C. After 20 h, the mixture was allowed to warm 
slowly to room temperature, then a saturated solution of NH4Cl (10 mL) 
was added and was extracted with ether (3 × 25 mL). The combined 
organic layers were washed with saturated brine solution (4 × 25 mL), 
dried (MgSO4), and the solvent was evaporated. Purification by flash 
silica chromatography, eluting with petrolÐEtOAc (95:5), gave the 
carbamate 6 (2.48 g, 70%) as needles; m.p. 110Ð112 ¼C; Rf 0.65 [petrolÐ
EtOAc (80:20)]; FT-IR νmax (film)/cm
Ð1 2980, 2945, 2855, 1690; 1H NMR 
(400 MHz, CDCl3, rotamers) δ = 7.54Ð7.19  (9H, m, 9  × CH), 5.17 (0.55H, 
br d, J = 12.0 Hz, NCH), 4.94 (0.45H, br d, J = 12.0 Hz, NCH), 3.08Ð2.89 
(1H, m, CH), 2.65 (1H, dd, J = 13.0, 8.0 Hz, CH), 2.04Ð1.90 (1H, m, CH), 
1.84Ð1.62 (2H, m, 2 × CH), 1.58Ð1.42 (1H, m, CH), 1.31 (9H, s, t-Bu); 
13C NMR (100 MHz, CDCl3, rotamers) δ = 154.9, 154.6, 146.5, 144.9, 
138.9, 138.8, 137.3, 137.2, 130.0, 129.8, 128.5, 128.4, 128.2, 128.1, 
127.2, 127.1, 126.9, 126.6, 126.5, 126.4, 126.0, 80.5, 79.8, 61.0, 59.4, 
32.1, 31.2, 29.7, 29.5, 28.3, 28.2, 23.7, 23.0; HRMS (ES) Found: MNa+, 
346.1779. C21H25NO2Na requires MNa
+, 346.1778; LRMS m/z (ES) 346 
(5%, MNa+), 268 (100%). 
tert-Butyl 2-(Tributylstannyl)-2,3,4,5-tetrahydro-2-
phenylbenzo[b]azepine-1-carboxylate 7a: nBuLi (0.15 mL, 0.37 mmol, 
2.4 M in hexane) was added to the carbamate 6 (100 mg, 0.31 mmol) in 
dry THF (2 mL) at Ð50 ¼C under nitrogen. After 10 minutes, tributyltin 
chloride (0.25 mL, 0.93 mmol) was added. The mixture was allowed to 
warm slowly to room temperature and MeOH (1 mL) was added. The 
solvent was evaporated and the mixture was absorbed onto silica then 
was purified by flash column chromatography on silica gel, eluting with 
petrolÐEtOAc (99:1), to give the carbamate 7a (142 mg, 75%) as an oil; 
Rf 0.75 [petrolÐEtOAc (80:20)]; FT-IR νmax (film)/cm
Ð1 2955, 2920, 2860, 
1670; 1H NMR (400 MHz, CDCl3) δ = 7.24Ð6.94 (9H, m, 9 × CH), 2.99Ð
2.86 (1H, m, CH), 2.60 (1H, dt, J = 9.0, 4.5 Hz, CH), 2.55Ð2.45 (1H, m, 
CH), 1.92Ð1.82 (2H, m, 2 × CH), 1.47Ð1.19 (22H, m, t-Bu, CH, 3 × 
CH2CH2), 0.87 (9H, t, J = 7.0 Hz, 3 × CH3), 0.83Ð0.65 (6H, m, 3 × CH2); 
13C NMR (100 MHz, CDCl3) δ = 156.8, 139.6, 138.4, 131.3, 130.3, 128.2, 
127.8, 126.8, 126.0, 125.0, 123.8, 79.8, 61.8, 35.2, 32.5, 29.1, 28.3, 27.7, 
22.6, 13.7, 13.5; HRMS (ES) Found: MNa+, 636.2841. C33H51NO2
120Sn 
Na requires MNa+, 636.2839; Found: MNa+, 634.2863. C33H51NO2
118Sn 
Na requires MNa+, 634.2860; LRMS m/z (ES) 636 (72%, MNa+), 634 (50, 
MNa+), 500 (35), 498 (25), 212 (100). 
tert-Butyl 2,3,4,5-Tetrahydro-2-methyl-2-phenylbenzo[b]azepine-1-
carboxylate 7b: nBuLi (0.15 mL, 0.37 mmol, 2.4 M in hexane) was 
added to the carbamate 6 (100 mg, 0.31 mmol) in dry THF (2 mL) at Ð50 
¼C under nitrogen. After 10 minutes, iodomethane (0.06 mL, 0.93 mmol) 
was added. The mixture was allowed to warm slowly to room 
temperature and MeOH (1 mL) was added. The solvent was evaporated 
and the mixture was absorbed onto silica then was purified by flash 
column chromatography on silica gel, eluting with petrolÐEtOAc (98:2), to 
give the carbamate 7b (62 mg, 60%) as an oil; Rf 0.65 [petrolÐEtOAc 
(80:20)]; FT-IR νmax (film)/cm
Ð1 2960, 2930, 2860, 1695; 1H NMR (400 
MHz, CDCl3, rotamers) δ = 7.56Ð7.15 (9H, m, 9 × CH), 3.20Ð2.87 (1H, m, 
CH), 2.72Ð2.60 (1H, m, CH), 2.12Ð1.89 (1H, m, CH), 1.81Ð1.43 (3H, m, 3 
× CH), 1.31Ð1.02 (12H, m, t-Bu and CH3); 
13C NMR (100 MHz, CDCl3, 
rotamers) δ = 156.2, 154.7, 145.1, 145.0, 138.9, 138.7, 137.2, 136.7, 
129.9, 129.5, 128.9, 128.2, 128.0, 127.2, 126.9, 126.7, 126.5, 126.3, 
126.0, 125.9, 125.6, 124.7, 80.5, 79.8, 61.4, 61.0, 32.2, 31.2, 30.3, 29.7, 
29.6, 28.3, 28.2, 28.0, 23.0, 21.6; HRMS (ES) Found: MH+, 338.2112. 
C22H28NO2 requires MH
+, 338.2115; LRMS m/z (ES) 338 (5%, MH+), 282 
(100). 
tert-Butyl 2-Allyl-2,3,4,5-Tetrahydro-2-phenylbenzo[b]azepine-1-
carboxylate 7c: nBuLi (0.15 mL, 0.37 mmol, 2.4 M in hexane) was 
added to the carbamate 6 (100 mg, 0.31 mmol) in dry THF (2 mL) at Ð50 
¼C under nitrogen. After 10 minutes, allyl bromide (0.08 mL, 0.93 mmol) 
was added. The mixture was allowed to warm slowly to room 
temperature and MeOH (1 mL) was added. The solvent was evaporated 
and the mixture was absorbed onto silica then was purified by flash 
column chromatography on silica gel, eluting with petrolÐEtOAc (98:2), to 
give the carbamate 7c (94 mg, 85%) as an oil; Rf 0.68 [petrolÐEtOAc 
(70:30)]; FT-IR νmax (film)/cm
-1 2965, 2925, 2850, 1695; 1H NMR (400 
MHz, CDCl3, rotamers) δ = 7.77Ð7.53 (1H, m, CH), 7.41Ð7.19 (8H, m, 8 × 
CH), 5.36Ð5.00 (1H, m, =CH), 4.99Ð4.58 (2H, m, =CH2), 3.03Ð2.83 (1H, 
m, CH), 2.73Ð2.62 (1H, m, CH), 2.54Ð2.12 (3H, m, 3 × CH), 2.03Ð1.86 
(1H, m, CH), 1.74Ð1.65 (1H, m, CH), 1.31 (3H, s, t-Bu), 1.12 (6H, s, t-Bu), 
0.99Ð0.88 (1H, m, CH); 13C NMR (100 MHz, CDCl3) δ = 155.5, 143.1, 
141.3, 134.7, 130.7, 129.1, 128.3, 127.5, 127.2, 126.6, 125.8, 125.4, 
118.2, 80.5, 68.1, 29.7, 27.9, 23.6, 23.1, 22.1; HRMS (ES) Found: MH+, 
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364.2272. C24H30NO2 requires MH
+, 364.2271; LRMS m/z (ES) 364 (5%, 
MH+), 308 (100). 
tert-Butyl 2-(4-Bromobutyl)-2,3,4,5-tetrahydro-2-
phenylbenzo[b]azepine-1-carboxylate 7d: nBuLi (0.15 mL, 0.37 mmol, 
2.4 M in hexane) was added to the carbamate 6 (100 mg, 0.31 mmol) in 
dry THF (2 mL) at Ð50 ¼C under nitrogen. After 10 minutes, 1,4-
dibromobutane (0.11 mL, 0.93 mmol) was added. The mixture was 
allowed to warm slowly to room temperature and MeOH (1 mL) was 
added. The solvent was evaporated and the mixture was absorbed onto 
silica then was purified by flash column chromatography on silica gel, 
eluting with petrolÐEtOAc (80:20), to give the carbamate 7d (109 mg, 
78%) as an oil; Rf 0.34 [petrolÐEtOAc (80:20)]; FT-IR νmax (film)/cm
-1 
2950, 2925, 2860, 1700; 1H NMR (400 MHz, CDCl3) δ = 7.71Ð7.12 (9H, 
m, 9 × CH), 3.17Ð3.05 (2H, m, 2 × CH), 2.89Ð2.77 (1H, m, CH), 2.74Ð
2.65 (1H, m, CH), 2.62Ð2.34 (2H, m, 2 × CH), 2.06Ð1.90 (1H, m, CH), 
1.73Ð1.56 (2H, m, 2 × CH), 1.54Ð1.43 (2H, m, 2 × CH), 1.34Ð1.25 (3H, m, 
3 × CH), 1.10 (9H, s, t-Bu); 13C NMR (100 MHz, CDCl3, one CH2 missing) 
δ = 153.4, 141.3, 134.1, 133.7, 130.6, 129.2, 128.5, 127.5, 126.7, 125.9, 
125.3, 80.2, 66.0, 39.7, 33.7, 33.3, 32.8, 29.7, 27.9, 22.5; HRMS (ES) 
Found: MNa+, 480.1507. C25H32
79BrNO2Na requires MNa
+, 480.1509; 
Found: MNa+, 482.1489. C25H32
81BrNO2Na requires MNa
+, 482.1492; 
LRMS m/z (ES) 482 (10%, MNa+), 480 (10, MNa+), 404 (100), 402 (100). 
5,5-Dimethyl-6-phenyl-4-oxa-2-azatricyclo[8.4.0.0
2,6
]tetradeca-
1(10),11,13-trien-3-one 7e: nBuLi (0.19 mL, 0.44 mmol, 2.4 M in hexane) 
was added to the carbamate 6 (100 mg, 0.31 mmol) in dry THF (2 mL) at 
Ð50 ¼C under nitrogen. After 10 minutes, acetone (0.07 mL, 0.93 mmol) 
was added. The mixture was allowed to warm slowly to room 
temperature and MeOH (1 mL) was added. The solvent was evaporated 
and the mixture was absorbed onto silica then was purified by flash 
column chromatography on silica gel, eluting with petrolÐEtOAc (95:5), to 
give the carbamate 7e (66 mg, 70%) as an oil; Rf 0.37 [petrolÐEtOAc 
(70:30)]; FT-IR νmax (film)/cm
-1 2965, 2925, 2855, 1745; 1H NMR (400 
MHz, CDCl3) δ = 7.58 (1H, d, J = 8.0 Hz, CH), 7.45Ð7.04 (8H, m, 8 × CH), 
2.86Ð2.68 (3H, m, 3 × CH), 2.28Ð2.17 (1H, m, CH), 1.99Ð1.88 (1H, m, 
CH), 1.56 (3H, s, CH3), 1.36Ð1.30 (1H, m, CH), 1.02 (3H, s, CH3); 
13C 
NMR (100 MHz, CDCl3) δ = 156.6, 139.5, 136.6, 136.5, 131.0, 130.6, 
129.6, 128.3, 127.5, 127.4, 127.1, 85.1, 72.3, 36.3, 35.9, 26.2, 21.2, 21.1; 
HRMS (ES) Found: MH+, 308.1648. C20H22NO2 requires MH
+, 308.1645; 
LRMS m/z (ES) 330 (10%, MNa+), 308 (100, MH+). 
5,6-Diphenyl-4-Oxa-2-azatricyclo[8.4.0.0!
,6
]tetradeca-1(10),11,13-
trien-3-one 7f: nBuLi (0.15 mL, 0.37 mmol, 2.4 M in hexane) was added 
to the carbamate 6 (100 mg, 0.31 mmol) in dry THF (2 mL) at Ð50 ¼C 
under nitrogen. After 10 minutes, benzaldehyde (0.09 mL, 0.93 mmol) 
was added. The mixture was allowed to warm slowly to room 
temperature and MeOH (1 mL) was added. The solvent was evaporated 
and a crude 1H NMR spectrum showed the product as a mixture of 
stereoisomers (15:1). The mixture was absorbed onto silica then was 
purified by flash column chromatography on silica gel, eluting with petrolÐ
EtOAc (75:25), to give the carbamate 7f (82 mg, 75%) (with the phenyl 
groups trans as verified by X-ray crystallography, see page S-22) as 
needles; m.p. 93Ð94 ¡C; Rf 0.43 [petrolÐEtOAc (70:30)]; FT-IR νmax 
(film)/cm-1 3065, 2925, 2850, 1750; 1H NMR (400 MHz, CDCl3) δ = 7.50 
(1H, d, J = 8 Hz, CH), 7.43Ð7.26 (9H, m, 9 × CH), 7.16Ð7.05 (4H, m, 4 × 
CH), 5.62 (1H, s, CH), 2.89Ð2.68 (2H, m, 2 × CH), 1.96Ð1.83 (3H, m, 3 × 
CH), 1.56Ð1.45 (1H, m, CH); 13C NMR (101 MHz, CDCl3) δ = 156.3, 
140.0, 138.0, 135.2, 133.1, 131.0, 130.3, 128.8, 128.6, 128.5, 128.3, 
128.2, 128.0, 127.8, 127.2, 126.8, 126.1, 125.9, 125.7, 88.8, 70.0, 35.4, 
33.6, 20.6; HRMS (ES) Found: MH+, 356.1645. C24H22NO2 requires MH
+, 
356.1645; LRMS m/z (ES) 356 (100%, MH+). 
tert-Butyl 2-(2-(Methoxycarbonyl)phenyl)-2,3,4,5-
tetrahydrobenzo[b]azepine-1-carboxylate 8a: nBuLi (0.15 mL, 0.37 
mmol, 2.4 M in hexane) was added to the carbamate 6 (100 mg, 0.31 
mmol) in dry THF (2 mL) at Ð50 ¼C under nitrogen. After 10 minutes, 
methyl cyanoformate (0.07 mL, 0.91 mmol) was added. The mixture was 
allowed to warm slowly to room temperature and MeOH (1 mL) was 
added. The solvent was evaporated and the mixture was absorbed onto 
silica then was purified by flash column chromatography on silica gel, 
eluting with petrolÐEtOAc (95:5), to give the carbamate 8a (71 mg, 68%) 
as an oil; Rf 0.43 [petrolÐEtOAc (60:40)]; FT-IR νmax (film)/cm
-1 2975, 
2940, 2860, 1720, 1695; 1H NMR (400 MHz, CDCl3, rotamer ratio 7:3) δ 
= 7.92 (1H, d, J = 8.0 Hz, CH), 7.64Ð7.43 (3H, m, 3 × CH), 7.42Ð7.36 (1H, 
m, CH), 7.35Ð7.20 (3H, m, 3 × CH), 5.96 (0.3H, d, J = 12.0 Hz, CH), 5.81 
(0.7H, d, J = 12.0 Hz, CH), 3.95 (3H, s, CH3), 3.07Ð2.90 (1H, m, CH), 
2.67 (1H, dd, J = 13.0, 7.0 Hz, CH), 2.16Ð2.03 (1H, m, CH), 1.96Ð1.87 
(1H, m, CH), 1.70Ð1.59 (1H, m, CH), 1.39Ð1.32 (1H, m, CH), 1.28 (3H, s, 
t-Bu), 1.18 (6H, s, t-Bu); 13C NMR (100 MHz, CDCl3, rotamers) δ = 167.6, 
167.3, 154.7, 154.3, 150.6, 149.1, 139.7, 139.3, 137.9, 137.2, 132.5, 
132.1, 130.6, 130.1, 129.7, 129.4, 128.6, 128.3, 128.0, 127.5, 127.1, 
126.9, 126.8, 126.4, 126.0, 125.7, 125.5, 125.3, 80.3, 80.1, 57.2, 56.6, 
52.3, 52.0, 31.8, 31.6, 29.7, 29.6, 28.2, 27.9, 24.0, 23.8; HRMS (ES) 
Found: MH+, 382.1942. C23H28NO4 requires MH
+, 382.1930; LRMS m/z 
(ES) 382 (100%, MH+). Alternatively, compound 8a was prepared by 
addition of methyl chloroformate (0.07 mL, 0.93 mmol), which gave the 
carbamate 8a (66 mg, 63%) as an oil; data as above. 
tert-Butyl 2,3,4,5-Tetrahydro-2-(2-
(phenylthio)phenyl)benzo[b]azepine-1-carboxylate 8b: nBuLi (0.15 
mL, 0.37 mmol, 2.4 M in hexane) was added to the carbamate 6 (100 mg, 
0.31 mmol) in dry THF (2 mL) at Ð50 ¼C under nitrogen. After 10 minutes, 
S-phenyl benzenethiosulfonate (0.23 mL, 0.93 mmol) was added. The 
mixture was allowed to warm slowly to room temperature and MeOH (1 
mL) was added. The solvent was evaporated and the mixture was 
absorbed onto silica then was purified by flash column chromatography 
on silica gel, eluting with petrolÐEtOAc (95:5), to give the carbamate 8b 
(110 mg, 85%) as an amorphous solid; m.p. 94Ð96 ¼C; Rf 0.42 [petrolÐ
EtOAc (60:40)]; FT-IR νmax (film)/cm
-1 2930, 2855, 1670; 1H NMR (400 
MHz, CDCl3, rotamers) δ = 7.69Ð7.08 (13H, m, 13 × CH), 5.17 (0.5H, d, J 
= 12.0 Hz, CH), 4.93 (0.5H, d, J = 12.0 Hz, CH), 3.10Ð2.88 (1H, m, CH), 
2.65 (1H, dd, J = 13.0, 8.0 Hz, CH), 2.04Ð1.89 (1H, m, CH), 1.83Ð1.62 
(2H, m, 2 × CH), 1.57Ð1.43 (1H, m, CH), 1.30 (9H, s, t-Bu); 13C NMR 
(100 MHz, CDCl3, rotamers) δ = 154.9, 154.7, 146.6, 145.0, 143.0, 142.7, 
138.9, 138.8, 137.3, 137.2, 136.6, 135.4, 133.6, 132.2, 131.6, 131.4, 
130.4, 130.0, 129.8, 129.5, 129.3, 129.1, 129.0, 128.8, 128.5, 128.4, 
128.3, 128.2, 127.9, 127.8, 127.6, 127.2, 126.9, 126.6, 126.5, 126.0, 
125.6, 125.4, 80.4, 79.8, 61.0, 59.4, 32.1, 31.2, 29.7, 29.5, 28.3, 28.2, 
23.7, 23.0; HRMS (ES) Found: MH+, 432.1909. C27H30NO2S requires 
MH+, 432.1906; LRMS m/z (ES) 432 (100%, MH+), 331 (45). 
11-Phenyl-1-azatricyclo[9.4.0.0
2,7
]pentadeca-2(7),3,5-triene 9: 
Trifluoroacetic acid (0.23 mL, 3.0 mmol) was added to the carbamate 7d 
(100 mg, 0.31 mmol) in CH2Cl2 (1 mL) at room temperature. After 1 h, the 
solvent was evaporated then CH2Cl2 (2 mL) and aqueous NaOH (5 mL, 2 
M) were added. After 15 min, the organic layer was separated, 
dried (MgSO4), and the solvent was evaporated. Purification by flash 
silica chromatography, eluting with petrolÐEtOAc (95:5), gave the amine 
9 (53 mg, 88%) as an oil; Rf 0.46 [petrolÐEtOAc (60:40)]; FT-IR νmax 
(film)/cm-1 2990, 2875, 2750, 1150; 1H NMR (400 MHz, CDCl3) δ = 7.60Ð
6.82 (9H, m, 9 × CH), 3.55Ð3.25 (2H, m, 2 × CH), 3.13Ð2.85 (1H, m, CH), 
2.79Ð2.46 (1H, m, CH), 2.34Ð2.08 (1H, m, CH), 1.91Ð1.83 (1H, m, CH), 
1.76Ð1.68 (1H, m, CH), 1.64Ð1.47 (5H, m, 5 × CH), 1.35Ð1.22 (2H, m, 2 
× CH); 13C NMR (100 MHz, CDCl3) δ = 141.9, 137.3, 134.9, 133.8, 128.5, 
128.2, 127.0, 125.7, 121.0, 120.3, 60.5, 47.9, 40.7, 30.6, 29.7, 26.2, 21.3, 
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19.8; HRMS (ES) Found: MH+, 278.1906. C20H24N requires MH
+, 
278.1903; LRMS m/z (ES) 278 (100%, MH+). 
Methyl 2-(2,3,4,5-Tetrahydro-1H-benzo[b]azepin-2-yl)benzoate 10: 
Trifluoroacetic acid (0.20 mL, 2.6 mmol) was added to the carbamate 8a 
(100 mg, 0.26 mmol) in CH2Cl2 (1 mL) at room temperature. After 1 h, the 
solvent was evaporated then CH2Cl2 (2 mL) and aqueous NaOH (5 mL, 2 
M) were added. After 15 min, the organic layer was separated, 
dried (MgSO4), and the solvent was evaporated. Purification by flash 
silica chromatography, eluting with petrolÐEtOAc (95:5), gave the amine 
10 (63 mg, 86%) as an oil; Rf 0.15 [petrolÐEtOAc (70:30)]; FT-IR νmax 
(film)/cm-1 3350, 2960, 2920, 1700; 1H NMR (400 MHz, CDCl3) δ = 8.03Ð
7.78 (2H, m, 2 × CH), 7.66Ð7.34 (3H, m, 3 × CH), 7.14Ð7.04 (1H, m, CH), 
6.99Ð6.69 (2H, m, 2 × CH), 4.50Ð4.40 (1H, m, CH), 3.86 (3H, s, CH3), 
2.95Ð2.83 (2H, m, 2 × CH), 2.22Ð2.02 (2H, m, 2 × CH), 1.97Ð1.83 (1H, m, 
CH), 1.59Ð1.51 (1H, m, CH); 13C NMR (100 MHz, CDCl3) δ = 168.2,  
149.1, 146.3, 138.6, 133.9, 132.4, 130.6, 129.8, 128.3, 127.1, 126.8, 
121.3, 120.3, 59.3, 52.3, 39.8, 35.8, 26.6; HRMS (ES) Found: MH+, 
282.1490. C18H20NO2 requires MH
+, 282.1489; LRMS m/z (ES) 282 
(100%, MH+). 
N,6-Dimethoxy-1,2,3,4-tetrahydronaphthalen-1-amine 12: O-
Methylhydroxylamine hydrochloride (2.83 g, 33.2 mmol) was added 
dropwise to 6-methoxy-1-tetralone 11 (4.87 g, 27.7 mmol) and pyridine 
(2.67 mL, 33.2 mmol) in methanol (60 mL) at room temperature. After 20 
h, the solvent was evaporated and the mixture was poured into water 
(300 mL). Aqueous HCl (100 mL, 1 M) was added and the mixture was 
extracted with CH2Cl2 (3 × 150 mL). The organic layers were washed 
with water (300 mL), dried (Na2SO4), and the solvent was evaporated to 
give the oxime (N,6-dimethoxy-3,4-dihydro-2H-naphthalen-1-imine) (5.19 
g, 91%) as an oil; Rf 0.41 [petrolÐEtOAc (80:20)]; FT-IR νmax (film)/cm
-1 
2940, 1615, 1590; 1H NMR (400 MHz, CDCl3) δ = 7.95 (1H, d, J = 9.0 Hz, 
CH), 6.78 (1H, dd, J = 9.0, 3.0 Hz, CH), 6.66 (1H, d, J = 3.0 Hz, CH), 
3.99 (3H, s, OCH3), 3.82 (3H, s, OCH3), 2.78Ð2.70 (4H, m, 4 × CH), 
1.90Ð1.81 (2H, m, 2 × CH); 13C NMR (100 MHz, CDCl3) δ = 160.2, 153.9, 
141.3, 125.8, 123.5, 112.9, 112.7, 61.8, 55.2, 30.1, 24.2, 21.5; HRMS 
(ES) Found: MH+, 206.1176. C12H15NO2, requires MH
+, 206.1176; LRMS 
m/z (ES) 206 (100%, MH+). Sodium cyanoborohydride (3.08 g, 60 mmol) 
was added dropwise to this oxime (10.0 g, 48 mmol) in methanol (100 
mL) at 15 ¼C. Methyl orange was added as an indicator and aqueous HCl 
(2 M) was added until the solution turned red. The mixture was stirred at 
room temperature for 24 h then aqueous NaOH (50 mL, 2 M) was added 
and the mixture was extracted with CH2Cl2 (4 × 40 mL). The organic 
layers were combined and washed with water (2 × 40 mL) and brine (20 
mL), then dried (MgSO4). The solvent was evaporated to give 
hydroxylamine 12 (6.22 g, 63%) as an oil; Rf 0.44 [petrolÐEtOAc (90:10)]; 
FT-IR νmax (film)/cm
-1 2940, 3400, 1610; 1H NMR (400 MHz, CDCl3) δ = 
7.26 (1H, d, J = 8.5 Hz, CH), 6.75 (1H, dd, J = 8.5, 3.0 Hz, CH), 6.65 (1H, 
d, J = 3.0 Hz, CH), 4.10 (1H, t, J = 4.5 Hz, CH), 3.79 (3H, s, OCH3), 3.60 
(3H, s, OCH3), 2.85Ð2.68 (2H, m, 2 × CH), 2.20Ð2.12 (1H, m, CH), 2.08Ð
1.96 (1H, m, CH), 1.84Ð1.71 (2H, m, 2 × CH); 13C NMR (100 MHz, CDCl3) 
δ = 158.7, 139.9, 130.7, 127.0, 113.6, 112.2, 62.3, 57.3, 55.2, 29.8, 26.4, 
18.1; HRMS (ES) Found: M+ÐNHOCH3, 161.0962. C11H13O requires M
+Ð
NHOCH3, 161.0961; LRMS m/z (ES) 161 (100%). 
tert-Butyl 2,3,4,5-Tetrahydro-7-methoxy-2-phenylbenzo[b]azepine-1-
carboxylate 13: Phenyllithium (2.50 mL, 4.80 mmol, 1.9 M in Et2O) was 
added dropwise to the hydroxylamine 12 (322 mg, 1.60 mmol) in dry 
Et2O (10 mL) at 0 ¼C. After 2 h, a solution of Boc2O (1.00 g, 4.80 mmol) 
in Et2O (10 mL) was added dropwise and the mixture was warmed to 
room temperature. After 16 h, Et2O (10 mL) was added. The mixture was 
washed with water (3 × 15 mL), dried (MgSO4), and the solvent was 
evaporated. Purification by flash silica chromatography, eluting with 
petrolÐEtOAc (90:10), gave the carbamate 13 (420 mg, 77%) as needles, 
m.p. 98Ð100 ¡C; Rf 0.26 [petrolÐEtOAc (80:20)]; FT-IR νmax (film)/cm
-1 
2930, 1690, 1600; 1H NMR (400 MHz, CDCl3, rotamers) δ = 7.38Ð7.20 
(5.5H, m, CH), 7.07 (0.5H, d, J = 8.5 Hz, CH), 6.86 (0.5H, dd, J = 8.5, 3.0, 
CH), 6.80Ð6.72 (1.5H, m, CH), 5.16 (0.5H, dd, J = 12.0, 3.0 Hz, CH), 4.91 
(0.5H, d, J = 12.0 Hz, CH), 3.84 (3H, s, CH3), 3.03Ð2.88 (1H, m, CH), 
2.64Ð2.54 (1H, m, CH), 2.01Ð1.89 (1H, m, CH), 1.83Ð1.65 (2H, m, 2 × 
CH), 1.56Ð1.47 (1H, m, CH), 1.33 (4H, s, t-Bu), 1.31 (5H, s, t-Bu); 13C 
NMR (100 MHz, CDCl3, rotamers) δ = 158.5, 158.3, 155.1, 155.0, 138.8, 
138.5, 132.2, 132.0, 131.6, 131.4, 130.8, 130.6, 128.3, 128.1, 126.65, 
126.6, 126.5, 126.1, 114.0, 113.5, 111.8, 111.5, 79.6, 79.4, 60.8, 59.2, 
55.4, 55.3, 32.0, 31.1, 30.1, 29.9, 28.3, 28.2, 23.6, 23.0; HRMS (ES) 
MNa+, 376.1885. C22H27NO3Na requires MNa
+, 376.1883; LRMS m/z (ES) 
376 (5%, MNa+), 298 (100). 
tert-Butyl 7-Methoxy-2-phenyl-2-(tributylstannyl)-4,5-dihydro-3H-1-
benzazepine-1-carboxylate 14: nBuLi (0.15 mL, 0.33 mmol, 2.4 M in 
hexane) was added to the carbamate 13 (100 mg, 0.28 mmol) in dry THF 
(2 mL) at Ð50 ¼C under nitrogen. After 10 minutes, tributyltin chloride 
(0.22 mL, 0.84 mmol) was added. The mixture was allowed to warm to 
room temperature over 16 h and MeOH (1 mL) was added. The solvent 
was evaporated and the mixture was adsorbed onto silica. Purification by 
flash column chromatography on silica gel, eluting with petrolÐEtOAc 
(99:1), gave the carbamate 14 (118 mg, 65%) as needles; m.p. 86Ð88 ¼C; 
Rf 0.53 [petrolÐEtOAc (90:10)]; FT-IR νmax (film)/cm
-1 2955, 1670, 1495; 
1H NMR (400 MHz, CDCl3) δ = 7.21 (2H, t, J = 8.0 Hz, 2 × CH), 7.12 (2H, 
br d, J = 8.0 Hz, CH), 6.98 (1H, t, J = 8.0 Hz, CH), 6.89 (1H, d, J = 9.0 Hz, 
CH), 6.62 (1H, d, J = 3.0 Hz, CH), 6.55 (1H, dd, J =  9.0, 3.0 Hz, CH), 
3.74 (3H, s, OCH3), 2.95Ð2.82 (1H, m, CH), 2.57Ð2.44 (2H, m, 2 × CH), 
1.90Ð1.80 (2H, m, 2 × CH), 1.40Ð1.30 (16H, m, t-Bu, CH, 3 × CH2), 1.28Ð
1.21 (6H, m, 3 × CH2), 0.86 (9H, t, J = 7.0 Hz, 3 × CH3), 0.82Ð0.63 (6H, 
m, 3 × CH2); 
13C NMR (100 MHz, CDCl3)  δ = 158.0, 157.2, 139.6, 132.5, 
130.9, 130.2, 128.8, 127.8, 123.7, 113.5, 110.8, 79.7, 68.2, 55.2, 30.4, 
29.1, 28.3, 27.7, 23.8, 23.0, 13.7, 13.5; HRMS (ES) Found: MNa+, 
666.2972. C34H53NO3
120SnNa requires MNa+, 666.2945; Found: MNa+, 
664.3000. C34H53NO3
118SnNa requires MNa+, 664.2940; LRMS m/z (ES) 
666 (100%), 664 (80). 
12-Methoxy-5,5-dimethyl-6-phenyl-4-oxa-2-
azatricyclo[8.4.0.0
2,6
]tetradeca-1(10),11,13-trien-3-one 15: nBuLi (0.15 
mL, 0.33 mmol, 2.4 M in hexane) was added to the carbamate 13 (100 
mg, 0.28 mmol) in dry THF (2 mL) at Ð50 ¼C under nitrogen. After 10 
minutes, acetone (0.06 mL, 0.84 mmol) was added. The mixture was 
allowed to warm to room temperature over 16 h and MeOH (1 mL) was 
added. The solvent was evaporated and the mixture was adsorbed onto 
silica. Purification by flash column chromatography on silica gel, eluting 
with petrolÐEtOAc (70:30), gave the carbamate 15 (74 mg, 78%) as 
needles; m.p. 139Ð142 ¼C; Rf 0.26 [petrolÐEtOAc (60:40)]; FT-IR νmax 
(film)/cm-1 2935, 1750, 1610; 1H NMR (400 MHz, CDCl3) δ = 7.48 (1H, d, 
J = 9.0 Hz, CH), 7.44Ð7.13 (5H, m, 5 × CH), 6.86 (1H, dd, J = 9.0, 3.0 Hz, 
CH), 6.59 (1H, d, J = 3.0 Hz, CH), 3.77 (3H, s, OCH3), 2.86Ð2.74 (2H, m, 
2 × CH), 2.67 (1H, dd, J = 13.0, 6.0 Hz, CH), 2.27Ð2.16 (1H, m, CH), 
1.98Ð1.89 (1H, m, CH), 1.54 (3H, s, CH3), 1.35Ð1.30 (1H, m, CH), 1.01 
(3H, s, CH3); 
13C NMR (100 MHz, CDCl3) δ = 158.4, 156.9, 141.1, 136.4, 
132.2, 129.2, 128.2, 127.9, 127.4, 115.6, 112.2, 84.9, 71.9, 55.3, 36.4, 
36.2, 26.1, 21.3, 21.1; HRMS (ES) Found: MH+, 338.1757. C21H24NO3 
requires MH+, 338.1751; LRMS m/z (ES) 360 (10%, MNa+), 338 (100, 
MH+). 
tert-Butyl 2-(2-(Ethoxycarbonyl)phenyl)-7-methoxy-2,3,4,5-
tetrahydro-1-benzazepine-1-carboxylate 16: nBuLi (0.15 mL, 0.33 
mmol, 2.4 M in hexane) was added to the carbamate 13 (100 mg, 0.28 
mmol) in dry THF (2 mL) at Ð50 ¼C under nitrogen. After 10 minutes, 
ethyl chloroformate (0.08 mL, 0.84 mmol) was added. The mixture was 
allowed to warm to room temperature over 16 h and MeOH (1 mL) was 
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added. The solvent was evaporated and the mixture was adsorbed onto 
silica. Purification by flash column chromatography on silica gel, eluting 
with petrolÐEtOAc (70:30), gave the carbamate 16 (72 mg, 60%) as an 
oil; Rf 0.52 [petrolÐEtOAc (70:30)]; FT-IR νmax (film)/cm
-1 2980, 1695, 
1500; 1H NMR (400 MHz, CDCl3, rotamers) δ = 7.91 (1H, d, J = 8.0 Hz, 
CH), 7.59Ð7.57 (1H, m, CH), 7.52Ð7.48 (1H, m, CH), 7.23Ð7.20 (1H, m, 
CH), 6.99Ð6.57 (3H, m, CH), 5.94 (0.25H, d, J = 12.0 Hz, CH), 5.77 
(0.75H, d, J = 12.0 Hz, CH), 4.45Ð4.37 (2H, m, OCH2), 3.86Ð3.82 (3H, m, 
OCH3), 3.79 (0.75H, s, OCH3), 3.00Ð2.93 (1H, m, CH), 2.64Ð2.58 (1H, m, 
CH), 2.56Ð2.43 (1H, m, CH), 2.39Ð2.20 (1H, m, CH), 1.97Ð1.86 (2H, m, 2 
× CH), 1.44 (3H, t, J = 7.0, Hz, CH3), 1.35 (2.5H, s, t-Bu), 1.18 (6.5H, s, t-
Bu); 13C NMR (100 MHz, CDCl3, rotamers) δ = 167.2, 166.6, 158.3, 
157.9, 155.0, 154.7, 150.4, 149.6, 138.5, 138.2, 132.3 (CH), 132.2 (CH), 
130.8, 130.7, 130.1 (CH), 130.0 (CH), 129.4, 129.3, 127.4, 127.3, 127.0, 
126.5, 125.9, 125.6, 113.9, 113.5, 111.7, 111.0, 80.1, 79.5, 61.1, 60.8, 
57.0, 56.4, 55.4, 55.3, 31.8, 31.5, 29.9, 29.7, 28.2, 27.9, 23.9, 23.8, 14.3, 
14.1; HRMS (ES) Found: MH+, 426.2282. C25H32NO5 requires MH
+, 
426.2275; LRMS m/z (ES) 426 (25%, MH+), 370 (100), 326 (60). 
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React-IR and VT-NMR spectroscopy (ΔGà 63 kJ/mol at Ð50 ¡C for Boc rotation) 
were used to optimise the lithiation of N-Boc-2-phenyltetrahydro-1-benzazepine. 
The intermediate organolithium was reacted with electrophiles to provide a 
selection of substituted products, with functionalisation either at C-2 or at the ortho 
position of the phenyl ring. 
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